Coronary stents are tube-shaped devices placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI). Coronary stents are tubular structures of a thin mesh of metal wires that are placed inside coronary arteries during PCIs for the treatment of individuals suffering from CADs. Stents reduce chest pain and have been shown to improve survivability in the event of an acute myocardial infarction.
The global coronary stents market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).
The global coronary stents market segmentation is based on product types (Bare Metal Stents, Drug Eluting Stents, Bio-absorbable Stents), and products in pipeline CORACTO, EXCELLA II and EXCELLA BD, DESolve Nx and DESolve FIM, ZoMaxx I and ZoMaxx II, ABSORB STEMI, BioFreedom, TAXUS PERSEUS, BioNIR).
The global coronary stents market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global coronary stents market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global coronary stents market and included in this report are Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic, Inc., Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, and C. R. Bard, Inc., Cook Medical, Inc., amg International GmbH, Biotronik SE & Co. KG, Stentys SA and MicroPort Scientific Corporation.